Injection Drug Use Surveillance Project

Forms and Documents

Document Name	Status
Injection Drug Use Surveillance Project Form and Instruction	Modified
Memo_Non-Substantive Change Request_0920-1325.docx Justification for No Material/Nonsubstantive Change	2021-03-31
Att 12 Sample Analysis Tables.docx Supplementary Document	2020-07-06
Privacy Act Checklist.docx Supplementary Document	2020-07-06
Att 9 Assurance of Confidentiality.docx Supplementary Document	2020-07-06
Att 8 Recruitment Coupon spreadsheet.xlsx Supplementary Document	2020-07-06
Att 4 Model Recruitment Coupon.pdf Supplementary Document	2020-07-06
Att 2a - Public Comment.docx Supplementary Document	2020-07-06
Att 1 Authorizing Legislation.docx Supplementary Document	2020-07-06
Supporting Statement B.docx Supporting Statement B	2020-06-22
Supporting Statement A.docx Supporting Statement A	2020-06-22

IC Document Collections

IC ID	Document Title	Status
242583	Injection Drug Use Surveillance Project Form and Instruction	Modified

ICR Details

OMB Control No: 0920-1325	ICR Reference No: 202103-0920-011
Status: Received in OIRA	Previous ICR Reference No: 202006-0920-011
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-21EF
Title: Injection Drug Use Surveillance Project
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 03/31/2021

	Requested	Previously Approved
Expiration Date	02/29/2024	02/29/2024
Responses	28,499	28,499
Time Burden (Hours)	6,125	6,125
Cost Burden (Dollars)	0	0

---

Abstract: The main goals of the Injection Drug Use (IDU) surveillance project are to assess the following among 6-30 syringe service programs (SSPs) in the US: 1) the risk behaviors, injection risk networks, receipt of prevention services, and barriers to prevention and care among persons who inject drugs (PWID) and their drug-using (i.e. either injecting or non-injecting) peers; and 2) the prevalence of HIV and Hepatitis C (HCV infections) among PWID and their drug-using peers.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 13655	03/09/2020
30-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 43838	07/20/2020
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Injection Drug Use Surveillance Project	n/a, N/A, N/A	Project Permission Form ,   Eligibility screening form ,   IDU Survey with proposed changes (March 2021)

---

ICR Summary of Burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	28,499	28,499	0	0	0	0
Annual Time Burden (Hours)	6,125	6,125	0	0	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $3,147,032

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 03/31/2021

---